Additionally, areas of high-grade UC specimens often exhibit negative tissue for HER2, indicating significant heterogeneity within UC, particularly in poorly differentiated tumors with a higher grade; thus suggesting that differences in HER2 overexpression may be linked to tumor heterogeneity. This evidence concerns the gene ERBB2 and neoplasm.